Table 3.
Outcomes of generalized linear models used to detect the significant predictors of blood oxidative status markers and of body condition index
Variable | Factor | Wald | P |
---|---|---|---|
Reactive oxygen metabolites | Experimental group | 4.73 | 0.030 |
Sampling year | 101.36 | <0.001 | |
Experimental group × sampling year | 0.34 | 0.559 | |
Nonenzymatic antioxidant capacity | Experimental group | 0.02 | 0.876 |
Sampling year | 47.24 | <0.001 | |
Experimental group × sampling year | 17.00 | <0.001 | |
Glutathione peroxidase | Experimental group | 5.15 | 0.023 |
Sampling year | 59.01 | <0.001 | |
Experimental group × sampling year | 10.13 | 0.002 | |
Superoxide dismutase | Experimental group | 0.89 | 0.346 |
Sampling year | 91.69 | <0.001 | |
Experimental group × sampling year | 1.69 | 0.194 | |
Body mass | Experimental group | 1.73 | 0.189 |
Sampling year | 2.52 | 0.112 | |
Forearm length | 16.79 | <0.001 | |
Experimental group × sampling year | 0.23 | 0.632 |
Notes: Significant P-values are shown in bold. The removal of the interaction when nonsignificant did not change the outcomes.